247 related articles for article (PubMed ID: 29069464)
21. Cortical activity differs during nicotine deprivation versus satiation in heavy smokers.
Evans DE; Sutton SK; Oliver JA; Drobes DJ
Psychopharmacology (Berl); 2015 Jun; 232(11):1879-85. PubMed ID: 25491928
[TBL] [Abstract][Full Text] [Related]
22. Cigarette smoking and nicotine addiction.
Benowitz NL
Med Clin North Am; 1992 Mar; 76(2):415-37. PubMed ID: 1548969
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological, sensorimotor, and expectancy effects on tobacco withdrawal: a preliminary study.
Guillot CR; Stone MD; Geary BA; Kirkpatrick MG; Tidey JW; Cook JW; Leventhal AM
Hum Psychopharmacol; 2015 Sep; 30(5):364-71. PubMed ID: 26010521
[TBL] [Abstract][Full Text] [Related]
24. Proactive tobacco treatment offering free nicotine replacement therapy and telephone counselling for socioeconomically disadvantaged smokers: a randomised clinical trial.
Fu SS; van Ryn M; Nelson D; Burgess DJ; Thomas JL; Saul J; Clothier B; Nyman JA; Hammett P; Joseph AM
Thorax; 2016 May; 71(5):446-53. PubMed ID: 26931362
[TBL] [Abstract][Full Text] [Related]
25. Treating tobacco use and dependence in clinical practice.
Cornuz J
Expert Opin Pharmacother; 2006 Apr; 7(6):783-92. PubMed ID: 16556092
[TBL] [Abstract][Full Text] [Related]
26. Effects of asthma on nicotine dependence development and smoking cessation attempts in adolescence.
Van De Ven MO; van Zundert RM; Engels RC
J Asthma; 2013 Apr; 50(3):250-9. PubMed ID: 23347267
[TBL] [Abstract][Full Text] [Related]
27. Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications.
D'Souza MS
Prog Brain Res; 2016; 223():191-214. PubMed ID: 26806777
[TBL] [Abstract][Full Text] [Related]
28. A cluster-randomized effectiveness trial of smoking cessation modified for at-risk smoker subgroups.
Batra A; Collins SE; Schröter M; Eck S; Torchalla I; Buchkremer G
J Subst Abuse Treat; 2010 Mar; 38(2):128-40. PubMed ID: 19819661
[TBL] [Abstract][Full Text] [Related]
29. Measurement of the effects of abstinence from tobacco: a qualitative review.
Hughes JR
Psychol Addict Behav; 2007 Jun; 21(2):127-37. PubMed ID: 17563132
[TBL] [Abstract][Full Text] [Related]
30. The effects of a prison smoking ban on smoking behavior and withdrawal symptoms.
Cropsey KL; Kristeller JL
Addict Behav; 2005 Mar; 30(3):589-94. PubMed ID: 15718077
[TBL] [Abstract][Full Text] [Related]
31. Socially anxious smokers experience greater negative affect and withdrawal during self-quit attempts.
Buckner JD; Langdon KJ; Jeffries ER; Zvolensky MJ
Addict Behav; 2016 Apr; 55():46-9. PubMed ID: 26790139
[TBL] [Abstract][Full Text] [Related]
32. Predictors of nicotine withdrawal symptoms: findings from the first randomized smoking cessation trial in a low-income country setting.
Ben Taleb Z; Ward KD; Asfar T; Jaber R; Auf R; Maziak W
Int J Public Health; 2016 Jul; 61(6):701-708. PubMed ID: 27083449
[TBL] [Abstract][Full Text] [Related]
33. Electronic nicotine devices to aid smoking cessation by alcohol- and drug-dependent clients: protocol for a pilot randomised controlled trial.
Guillaumier A; Manning V; Wynne O; Gartner C; Borland R; Baker AL; Segan CJ; Skelton E; Moore L; Bathish R; Lubman DI; Bonevski B
Trials; 2018 Aug; 19(1):415. PubMed ID: 30071863
[TBL] [Abstract][Full Text] [Related]
34. Translational Research on Nicotine Dependence.
Falcone M; Lee B; Lerman C; Blendy JA
Curr Top Behav Neurosci; 2016; 28():121-50. PubMed ID: 26873019
[TBL] [Abstract][Full Text] [Related]
35. Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial.
Rabin RA; Ashare RL; Schnoll RA; Cinciripini PM; Hawk LW; Lerman C; Tyndale RF; George TP
Am J Addict; 2016 Jun; 25(4):291-6. PubMed ID: 27187893
[TBL] [Abstract][Full Text] [Related]
36. Coping with urges to smoke: what is a clinician to do?
Modesto-Lowe V; Chmielewska A
Conn Med; 2013 May; 77(5):289-94. PubMed ID: 23777042
[TBL] [Abstract][Full Text] [Related]
37. Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment.
Bozinoff N; Le Foll B
Expert Rev Respir Med; 2018 Sep; 12(9):793-804. PubMed ID: 30092681
[TBL] [Abstract][Full Text] [Related]
38. The role of pain in quitting among human immunodeficiency virus (HIV)-positive smokers enrolled in a smoking cessation trial.
Aigner CJ; Gritz ER; Tamí-Maury I; Baum GP; Arduino RC; Vidrine DJ
Subst Abus; 2017; 38(3):249-252. PubMed ID: 28328303
[TBL] [Abstract][Full Text] [Related]
39. Policies Affecting Medicaid Beneficiaries' Smoking Cessation Behaviors.
Brantley EJ; Greene J; Bruen BK; Steinmetz EP; Ku LC
Nicotine Tob Res; 2019 Jan; 21(2):197-204. PubMed ID: 29522120
[TBL] [Abstract][Full Text] [Related]
40. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
